Status:
RECRUITING
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
45-75 years
Phase:
NA
Brief Summary
Breast cancer (BC) is the most frequently diagnosed cancer in women. Systemic cancer treatments are an important contributor to dramatic improvements in the long-term survival of women with BC. Howeve...
Eligibility Criteria
Inclusion
- Stage II-IV hormone receptor+, breast cancer diagnosis
- Post-menopausal (defined as at least 1-year post menses, on ovarian suppression medication, or s/p oophorectomy)
- Within 4 weeks before or 12 weeks after starting initial systemic therapies (e.g. chemotherapy, targeted therapies such as CDK4/6 inhibitors, endocrine therapy)
- Ability to access and use internet resources, including video calls using Zoom platform
- English speaking
Exclusion
- History of dementia, stroke, traumatic brain injury, brain metastasis or other conditions that could lead to cognitive impairment
- MIND diet score \>8
- Unwilling/unable to eat \>2 types of MIND food
- Receiving insulin therapy for diabetes
- Diagnosis of triple negative breast cancer
- Unable to give informed consent.
Key Trial Info
Start Date :
October 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT05984888
Start Date
October 26 2023
End Date
December 1 2027
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210